1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Belarus Pharmaceuticals and Healthcare Report Q4 2016

Belarus Pharmaceuticals and Healthcare Report Q4 2016

  • August 2016
  • -
  • Business Monitor International
  • -
  • 74 pages

Includes 3 FREE quarterly updates

BMI View: Government initiatives to reduce the reliance on pharmaceutical imports pose challenges formultinational drugmakers. The weak ruble has seen prices of foreign medicines rise to unaffordable levelsand has led to state intervention in the form of domestic bias in the medicine tendering process, pricingcontrols and initiatives to boost the domestic drug-making industry. A poor economic outlook furtherdeepens the risk to revenue earning opportunities.Headline Expenditure ProjectionsPharmaceuticals: BYR12,247bn in 2015 (USD770mn) to BYR14,354bn (USD740mn) in 2016; +17.2% inlocal currency terms and -4.0% in US dollar terms. Forecast unchanged from last quarter.Healthcare: BYR47,930bn (USD3.00bn) in 2015 to BYR52,246bn (USD2.68bn) in 2016; +9.0% in localcurrency terms and -10.7% in US dollar terms. Forecast unchanged from last quarter.

Table Of Contents

Belarus Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Belarus 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Belarus 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Belarus 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Belarus 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Belarus 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Belarus 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Belarus 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Belarus 2014-2020) 30
Industry Risk Reward Index 31
Central And Eastern Europe Risk/Reward Index - Q4 2016 31
Belarus Risk/Reward Index 38
Rewards 38
Risks 39
Regulatory Review 40
Intellectual Property Issues 41
Pricing And Reimbursement Regime 43
Market Overview 45
Healthcare Sector 46
Table: Healthcare Resources (Belarus 2010-2015) 49
Table: Healthcare Personnel (Belarus 2010-2015) 49
Table: Healthcare Activity (Belarus 2010-2015) 50
Research And Development 50
Clinical Trials 51
Epidemiology 52
Competitive Landscape 56
Research-Based Industry 56
Table: Multinational Market Activity 57
Generic Drugmakers 57
Pharmaceutical Distribution 59
Pharmaceutical Retail Sector 59
Company Profile 60
Lekpharm 60
Demographic Forecast 63
Demographic Outlook 63
Table: Population Headline Indicators (Belarus 1990-2025) 64
Table: Key Population Ratios (Belarus 1990-2025) 64
Table: Urban/Rural Population and Life Expectancy (Belarus 1990-2025) 65
Table: Population By Age Group (Belarus 1990-2025) 65
Table: Population By Age Group % (Belarus 1990-2025) 66
Glossary 68
Methodology 70
Pharmaceutical Expenditure Forecast Model 70
Healthcare Expenditure Forecast Model 70
Notes On Methodology 71
Risk/Reward Index Methodology 72
Index Overview 73
Table: Pharmaceutical Risk/Reward Index Indicators 73
Indicator Weightings 74

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Atrial Fibrillation - Global Drug Forecast and Market Analysis to 2025 Summary Atrial fibrillation (AF) is the most common cardiac arrhythmia and is a heart condition that causes an irregula ...

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • August 2016
  • by Global Data

PharmaPoint: Venous Thromboembolism - Global Drug Forecast and Market Analysis to 2025 Summary Venous thromboembolism (VTE) is a disease that includes a myriad of life-threatening disorders ranging from ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.